HALO logo
halo search icon
BAVA
Bavarian Nordic A/S

BAVA · Bavarian Nordic A/S

213.00

DKK
3.60 (1.72%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr16.59B

PE

10.80

EV/EBITDA

7.1

DIV Yield

0%

Payout Ratio

0%

MQV Rating

4Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • EMA 125 Breakup
  • Extreme Overbought
  • Extreme Overbought (Realtime)
  • HALO 100
  • HALO 50
  • HALO All
  • HALO Balance Sheet
  • HALO Consensus Value
  • HALO Earnings Momentum
  • HALO Small
  • Hammer Bullish (Realtime)
  • Near Resistance
  • Near Resistance (Realtime)
  • Recent Earnings upgrade
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-457.30%

EBITDA Margin

26.50%

Operating Cashflow

kr2,722m

Free Cash Flow Return

22.30%

ROIC

11.30%

Interest Coverage

124.50

Quick Ratio

2.60

Performance

52 weeks range

Low 171.3 - 244.8

Trade Value (12mth)

US$2,444,900.00

1 week

12.64%

1 month

20.07%

YTD

8.61%

1 year

-11.83%

All time high

411.00

Additional Data

Shares Outstanding (Fully Diluted)

76m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

DKK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Weak

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Arbejdsmarkedets TillægspensionPension Fund
Bavarian Nordic A/SPublic Company
Frank A. G. M. VerwielIndividual
Anne Louise EberhardIndividual
Anja GjølIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
The current share price of Bavarian Nordic A/S (BAVA:CSE) is DKKkr213.00.
2
What is the 52-week high share price for Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
The 52-week high share price for Bavarian Nordic A/S (BAVA:CSE) is DKKkr244.80.
3
What is the 52-week low share price for Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
The 52-week low share price for Bavarian Nordic A/S (BAVA:CSE) is DKKkr171.30.
4
What is the dividend yield for Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
Bavarian Nordic A/S (BAVA:CSE) does not pay a dividend.
5
What was Bavarian Nordic A/S (BAVA:CSE) last dividend payment?
Halo FAQ
Bavarian Nordic A/S (BAVA:CSE) does not pay a dividend.
6
What is the franking level for Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
Bavarian Nordic A/S (BAVA:CSE) has a franking level of 0.00%.
7
In which sector is Bavarian Nordic A/S (BAVA:CSE) classified?
Halo FAQ
Bavarian Nordic A/S (BAVA:CSE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Bavarian Nordic A/S (BAVA:CSE)?
Halo FAQ
The current P/E ratio for Bavarian Nordic A/S (BAVA:CSE) is 10.80.